Arye Weigensberg - 10 May 2025 Form 4 Insider Report for Cronos Group Inc. (CRON)

Role
Senior Vice President, Head of Research and Development
Signature
/s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg
Issuer symbol
CRON
Transactions as of
10 May 2025
Net transactions value
$0
Form type
4
Filing time
13 May 2025, 18:35:37 UTC
Previous filing
18 Mar 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weigensberg Arye Senior Vice President, Head of Research and Development 4491 CONCESSION RD 12, STAYNER, ONTARIO, CANADA /s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg 13 May 2025 0001937121

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRON COMMON SHARES Options Exercise $0 +3,118 +2.7% $0.000000 120,455 10 May 2025 Direct F1
transaction CRON COMMON SHARES Options Exercise $0 +9,014 +7.5% $0.000000 129,469 12 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRON RESTRICTED STOCK UNITS Options Exercise $0 -3,118 -1.8% $0.000000 169,355 10 May 2025 COMMON SHARES 3,118 Direct F1, F2
transaction CRON RESTRICTED STOCK UNITS Options Exercise $0 -9,014 -5.3% $0.000000 160,341 12 May 2025 COMMON SHARES 9,014 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
F2 On May 10, 2024, the reporting person was granted 9,355 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3 On May 12, 2022, the reporting person was granted 27,040 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Remarks:

Senior Vice President, Head of Research and Development